NCT06951893

Brief Summary

This study aims to identify pre-operative phenotypic determinants predictive of quality of life trajectories in post-bariatric surgery patients. In addition, this study will have as a secondary objective the highlighting of a potential link between post-surgery quality of life trajectories and those of anxiety/depression scores, eating behaviors and body mass indices. This study will be conducted during the usual care of patients undergoing the GEROM73 program, lasting a total of 30 months. The GEROM73 program includes care for the six months preceding bariatric surgery and the 24 months following surgery. This program supports patients throughout their bariatric care.. Throughout the GEROM73 program, patients will complete questionnaires on anxiety, depression, eating disorders, Impact of Weight on Quality Of Life. Patients' weight, body mass index and body schema will also be measured throughout the GEROM program.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
165

participants targeted

Target at P75+ for not_applicable

Timeline
55mo left

Started May 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
May 2025Nov 2030

First Submitted

Initial submission to the registry

April 23, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 30, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2030

Last Updated

May 7, 2025

Status Verified

May 1, 2025

Enrollment Period

5.5 years

First QC Date

April 23, 2025

Last Update Submit

May 5, 2025

Conditions

Keywords

GEROM73PHENOBEQOL73

Outcome Measures

Primary Outcomes (1)

  • Time trajectories of EQVOD score during the 24 months post-surgery from measurements at M12, M18 and M24 according to phenotypic characteristics measured during the final pre-surgical assessment (M-1 of bariatric surgery)

    Trajectory identification using latent class mixed models to classify patients into distinct EQVOD score trajectories over the 24 months post-surgery. The relationship between the 7 pre-surgery phenotypic characteristics and membership in the different trajectory classes will be tested in a multinomial logistic regression.

    one month befre surgery to 24 month post surgery

Secondary Outcomes (3)

  • quality of life trajectory groups defined by the analysis of the primary outcome measure, comparated to anxiety and depression measured at 12, 18 and 24 months.

    12, 18 and 24 month after surgery

  • quality of life trajectory groups defined by the analysis of the primary outcome measure, comparated to Dutch Eating Behavior measured at 12, 18 and 24 months.

    12, 18 and 24 months after surgery

  • quality of life trajectory groups defined by the analysis of the primary outcome measure, comparated to Impact of Weight on Quality Of Life at 12, 18 and 24 months.

    12, 18 and 24 month after surgery

Other Outcomes (2)

  • Body schema measured at pre-surgical (M-6 and end of pre-operative course M-1) and post-surgical (M+12 and M+24) assessments.

    at 6 and 1 month before surgery, and at 12, 18 and 24 months before surgery

  • Body schema measured at pre-surgical (M-6 and end of pre-operative course M-1) and post-surgical (M+12 and M+24) assessments compared between the quality of life trajectory groups defined by the analysis of the primary judgment criterion

    at 6 and 1 month before surgery, and at 12, 18 and 24 months before surgery

Study Arms (1)

phenotype of patients during the GEROM73 program

EXPERIMENTAL

Anxiety, Depression, Eating disorders, Impact of Weight on Quality Of Life.Patients' weight, Body Mass index and Body schema

Other: Hospital Anxiety and Depression ScaleOther: Dutch Eating Behaviour QuestionnaryOther: Impact of Weight on Quality Of LifeOther: body schemaOther: body mass indexOther: waist size

Interventions

It is a self-assessment questionnaire to identify the existence of anxious and depressive symptoms and to assess their severity.

phenotype of patients during the GEROM73 program

It allows the assessment of 3 distinct factors of eating behavior: cognitive restriction, emotional eating and externality. This tool was developed to better characterize the eating habits of obese subjects. 10min

phenotype of patients during the GEROM73 program

The EQVOD is a validated French scale created from the Impact of Weight on Quality of Life (IWQOL) questionnaire. This self-administered questionnaire is specific to the sociocultural factors of obesity and its dietary treatment in France. The questionnaire is composed of five dimensions: physical impact (11 items), psychosocial impact (11 items), impact on sexual life (4 items), dietary well-being (5 items), and experience of diet/dietetics (5 items). The total number of items is 36.

phenotype of patients during the GEROM73 program

Tactile assessment of the body schema using a motorized caliper applied to different parts of the individual's body. The caliper is connected to a touch pad on which the person can report the difference felt between the two pressure points on their skin, using their thumb and index finger.

phenotype of patients during the GEROM73 program

patient weighing at each visit

phenotype of patients during the GEROM73 program

waist size measure

phenotype of patients during the GEROM73 program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patient \> 18years old
  • Integrated into the GEROM73 surgical program and starting the intra-hospital program

You may not qualify if:

  • Patients in a state of psychiatric decompensation
  • Patients with cognitive disorders
  • Patients with difficulties understanding the French language, spoken or written
  • Pregnant, parturient, or breastfeeding women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Métropole Savoie

Chambéry, Savoie, 73011, France

Location

MeSH Terms

Conditions

Obesity, MorbidObesityOverweight

Interventions

4-amino-4'-hydroxylaminodiphenylsulfoneBody Mass Index

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Body Weights and MeasuresBody ConstitutionPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisAnthropometryInvestigative TechniquesPhysiological PhenomenaBiometryEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Study Officials

  • Cécile BOSSU ESTOUR

    CH Metropole Savoie

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: each patient will complete questionary 6month before surgery, and then 12, 18 and 24 months after the surgery
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2025

First Posted

April 30, 2025

Study Start

May 1, 2025

Primary Completion (Estimated)

November 1, 2030

Study Completion (Estimated)

November 1, 2030

Last Updated

May 7, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations